|New Threads Only:|
|New Threads & Replies:|
Forum List » Guru News and Commentaries|
Guru News, Stock picks and commentaries
CEO of Vitamin Shoppe Anthony N. Truesdale Sold 31,807 Shares
Posted by: GuruFocus (IP Logged)
Date: August 17, 2012 04:46PM
Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. Vitamin Shoppe Inc. has a market cap of $1.7 billion; its shares were traded at around $54.44 with a P/E ratio of 29.7 and P/S ratio of 2.
CEO of Vitamin Shoppe Inc. (VSI) Anthony N. Truesdale sold 31,807 shares on Aug. 16, 2012 at an average price of $56.85. The total transaction amount was $1,808,228.
Anthony Truesdale joined Vitamin Shoppe in 2006 as president and chief merchandising officer. In 2011, he was promoted to his current position. Before coming to the company, Mr. Truesdale served in many executive positions at PetSmart Inc. for seven years.
On Aug. 13, 2012, CEO Anthony N. Truesdale sold 110,952 shares of VSI stock at the average price of 56.63. Former President and COO Michael G. Archbold, Executive Chairman of the Board Richard L. Markee, and Director B. Michael Becker also sold shares of VSI stock.
Vitamin Shoppe announced their 2012 second quarter results. The company reported revenues of $244.98 million and net income of $16.6 million.
Stocks Discussed: VSI,
Posted by: fmyykjk (IP Logged)
Date: February 19, 2016 12:10PM
Selamectin (trade names Revolution, Stronghold) is a topical parasiticide and antihelminthic used on dogs and cats, distributed by Zoetis, a former Pfizer subsidiary. It treats and prevents infections of heartworms, fleas, ear mites, sarcoptic mange (scabies), and certain types of ticks in dogs, and prevents heartworms, fleas, ear mites, hookworms, and roundworms in cats. It is structurally related to ivermectin and milbemycin. Selamectin is not approved for human use.
From suzhou pharmaceutical technology co.,ltd.
Stocks Discussed: VSI,
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.